The effect of adrenaline and of alpha- and beta- adrenergic blocking agents on 32P incorporation into fat-cell phospholipids.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D010710:Phosphates / Q000378:metabolism*; D010743:Phospholipids / Q000096:biosynthesis*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D010710:Phosphates; D010743:Phospholipids; D013565:Sympatholytics; D011433:Propranolol; D000242:Cyclic AMP; D004837:Epinephrine; D010646:Phentolamine